AmpliPhi Presents Case Study of Bacteriophage Used to Treat Drug Resistant Infection in Cystic Fibrosis Patient

AmpliPhi Presents Case Study of Bacteriophage Used to Treat Drug Resistant Infection in Cystic Fibrosis Patient

Submitted by CP Staff on June 7, 2018 - 9:33am
Source: 
CP Wire
News Tags: 
Ampliphi Biosciences
cystic fibrosis
MDR pneumonia
AB-PA01
bacteriophage
Headline: 
AmpliPhi Presents Case Study of Bacteriophage Used to Treat Drug Resistant Infection in Cystic Fibrosis Patient
snippet: 

AmpliPhi Biosciences Corporation (NYSE American: APHB) announced on 5/7/2018 a poster presentation of a successful case study of a patient with cystic fibrosis, suffering from recurrent multi-drug resistant (MDR)  Pseudomonas aeruginosa  (P. aeruginosa) pneumonia, who received treatment with AB-PA01, AmpliPhi’s investigational bacteriophage drug candidate.

Do Not Allow Advertisers to Use My Personal information